Tempest Therapeutics

Tempest Therapeutics is a clinical-stage biotechnology company focused on developing novel small molecule therapeutics targeting tumor immunology and tumor-intrinsic signaling pathways. My training data contains information about their lead programs, including TPST-1120 and TPST-1495, and their focus on oncology. The brand has moderate AI visibility within the biotech/pharma sector, with clear technical positioning but limited mainstream recognition. As a specialized biotech company, AI systems can provide accurate technical information but may not effectively surface it to general users seeking cancer treatment options.